Economic Impact of the End of the Market Exclusivity for Orphan Drugs

Value in Health - United Kingdom
doi 10.1016/j.jval.2015.09.2012
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

PHP46 Market Uptake of Orphan Drugs – A European Analysis

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2011English

Potential Impact of the Cancer Drugs Fund Reform on Orphan Cancers

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2016English

Psy49 - Budgetary Impact of Orphan Drugs in the Catalan Healthcare Service

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Examining the Target Population of Orphan Drugs: Are Drugs Exceeding the Intended Purposes of the Orphan Drug Act?

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Pricing and Reimbursement of Orphan Drugs: The Need for More Transparency

Orphanet Journal of Rare Diseases
MedicineGeneticsPharmacology
2011English

Prm34 - French Efficiency Opinions of the Economic and Public Health Committee (Ceesp): Is There an Impact on the Market Access for Innovative Drugs?

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

The Economic Impact of Herd Behavior in the Japanese Loan Market

Pacific Basin Finance Journal
EconomicsEconometricsFinance
2012English

Php325 - Orphan Drugs‘ Market Access Challenges in Europe From a German Perspective

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

The Impact of Stock Market Development on Economic Growth: The Case of Botswana

International Journal of Economics and Finance
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy